
Sequana Medical NV
XBRU:SEQUA

Intrinsic Value
The intrinsic value of one
SEQUA
stock under the Base Case scenario is
1.075
EUR.
Compared to the current market price of 0.932 EUR,
Sequana Medical NV
is
Undervalued by 13%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Sequana Medical NV
Fundamental Analysis


Revenue & Expenses Breakdown
Sequana Medical NV
Balance Sheet Decomposition
Sequana Medical NV
Current Assets | 7.1m |
Cash & Short-Term Investments | 4.2m |
Receivables | 959k |
Other Current Assets | 2m |
Non-Current Assets | 3.6m |
Long-Term Investments | 97.7k |
PP&E | 3.5m |
Free Cash Flow Analysis
Sequana Medical NV
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Sequana Medical NV
Revenue
|
433.5k
EUR
|
Cost of Revenue
|
-4.1m
EUR
|
Gross Profit
|
-3.6m
EUR
|
Operating Expenses
|
-19.4m
EUR
|
Operating Income
|
-23m
EUR
|
Other Expenses
|
-4.1m
EUR
|
Net Income
|
-27.2m
EUR
|
SEQUA Profitability Score
Profitability Due Diligence
Sequana Medical NV's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Score
Sequana Medical NV's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
SEQUA Solvency Score
Solvency Due Diligence
Sequana Medical NV's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Score
Sequana Medical NV's solvency score is 24/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SEQUA Price Targets Summary
Sequana Medical NV
According to Wall Street analysts, the average 1-year price target for
SEQUA
is 4.046 EUR
with a low forecast of 2.929 EUR and a high forecast of 5.25 EUR.
Dividends
Current shareholder yield for SEQUA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
SEQUA
stock under the Base Case scenario is
1.075
EUR.
Compared to the current market price of 0.932 EUR,
Sequana Medical NV
is
Undervalued by 13%.